Tanaka E, Inoue E, Shoji A, Nilsson J, et al. Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLoS One 2022;17:e0277566.
PMID: 36383610